Pregnancy SmartSiteTM
Albright hereditary osteodystrophy; Types 1A and 1B pseudohypoparathyroidism; PHP DefinitionPseudohypoparathyroidism (PHP) is a genetic disorder in which the body fails to respond to parathyroid hormone. A related condition is hypoparathyroidism, in which the body does not make enough parathyroid hormone. CausesThe parathyroid glands produce parathyroid hormone (PTH). PTH helps regulate calcium, phosphorus, and vitamin D levels in the blood and is important for bone health. If you have PHP, your body produces the right amount of PTH, but is resistant to its effect. This causes low blood calcium levels and high blood phosphate levels. PHP is caused by abnormal genes. There are different types of PHP. All forms are rare and are usually diagnosed in childhood.
SymptomsSymptoms are related to a low level of calcium and include:
People with Albright hereditary osteodystrophy may have the following symptoms:
Exams and TestsBlood tests will be done to check calcium, phosphorus, and PTH levels. You may also need urine tests. Other tests may include:
TreatmentYour health care provider will recommend calcium and vitamin D supplements to maintain a proper blood calcium level. If the blood phosphate level is high, you may need to follow a low-phosphorus diet or take medicines called phosphate binders (such as calcium carbonate or calcium acetate). Treatment is usually life-long. Outlook (Prognosis)Low blood calcium in PHP is usually milder than in other forms of hypoparathyroidism, but the severity of symptoms can be different between different people. Possible ComplicationsPeople with type 1a PHP are more likely to have other endocrine system problems (such as hypothyroidism and hypogonadism). PHP may be connected to other hormone problems, resulting in:
When to Contact a Medical ProfessionalContact your provider if you or your child have any symptoms of a low calcium level or pseudohypoparathyroidism. ReferencesBastepe M, Juppner H. Pseudohypoparathyroidism, Albright's hereditary osteodystrophy, and progressive osseous heteroplasia: disorders caused by inactivating GNAS mutations that reduce Gsa activity. In: Robertson RP, ed. DeGroot's Endocrinology. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 57. Hanley PC, Doyle DA. Pseudohypoparathyroidism. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 612. Thakker RV. The parathyroid glands, hypercalcemia, and hypocalcemia. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 227. | |
| |
Review Date: 5/20/2024 Reviewed By: Sandeep K. Dhaliwal, MD, board-certified in Diabetes, Endocrinology, and Metabolism, Springfield, VA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language. © 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited. | |